Advances in the fields of IMRT and functional imaging have greatly increased the prospect of escalating the dose to highly active or hypoxic tumour sub-volumes and steering the dose away from highly functional critical structure regions. However, current clinical treatment planning and evaluation tools assume homogeneous activity/function status in the tumour/critical structures. A method was developed to incorporate tumour/critical structure heterogeneous functionality in the generalized concept of equivalent uniform dose (EUD). The tumour and critical structures functional EUD (FEUD) values were calculated from the dose-function histogram (DFH), which relates dose to the fraction of total function value at that dose. The DFH incorporates flouro-deoxyglucose positron emission tomography (FDG-PET) functional data for tumour, which describes the distribution of metabolically active tumour clonogens, and single photon emission computed tomography (SPECT) perfusion data for critical structures. To demonstrate the utility of the method, the lung dose distributions of two non-small cell lung caner patients, who received 3D conformal external beam radiotherapy treatment with curative intent, were evaluated. Differences between the calculated lungs EUD and FEUD values of up to 50% were observed in the 3D conformal plans. In addition, a non-small cell lung cancer patient was inversely planned with a target dose prescription of 76 Gy. Two IMRT plans (plan-A and plan-B) were generated for the patient based on the CT, FDG-PET and SPECT treatment planning images using dose-volume objective functions. The IMRT plans were generated with the goal of achieving more critical structures sparing in plan-B than plan-A. Results show the target volume EUD in plan-B is lower than plan-A by 5% with a value of 73.31 Gy, and the FEUD in plan-B is lower than plan-A by 2.6% with a value of 75.77 Gy. The FEUD plan-B values for heart and lungs were lower than plan-A by 22% and 18%, respectively. While EUD values show plan-A is marginally better than plan-B in terms of target volumetric coverage, the FEUD plan-B values show adequate
target function coverage with significant critical structure function sparing. In conclusion, incorporating functional data in the calculation of EUD is important in evaluating the biological merit of treatment plans.
Introduction
Recent advances in the field of intensity modulated radiation therapy (IMRT) and positron emission tomography/single photon emission computed tomography/functional MRI (PET/SPECT/fMRI) imaging have greatly increased the prospect of escalating the dose to tumour sub-volumes with high activity or low radiosensitivity and steering the dose away from critical structure regions with high function (Xing et al 2002 , Alber et al 2003 .
FDG-PET images provide functional data regarding the distribution and proliferative potential of metabolically active tumour clonogens and SPECT perfusion images provide information on blood flow in critical structure sub-units, thus complementing the CT-derived information. Recent articles have shown that higher pre-treatment flouro-deoxyglucose (FDG) uptake, as measured by the specific uptake value, correlates to worse outcome, as measured by local control and survival (Halfpenny et al 2002 , Jeong et al 2002 , Eary et al 2002 . This makes FDG-PET an effective tool for diagnosing and staging of malignant lesions. Radiotherapy (RT) treatment plans can be designed based on the ability of FDG-PET data to detect the lesion metabolic activity. For organs at risk, SPECT imaging maps the perfusion distribution, and thus identifies regions of high and low function (Boersma et al 1993 , Marks et al 1993 . Treatment plans can be designed using SPECT data to avoid critical structure regions with high function which is usually not detected on CT scans (Das et al 2003) . Seppenwoolde et al (2002) demonstrated that lung treatment plans generated based on perfusion-weighted optimization result in less radiation damage to functioning lung, compared to geometrically optimized plans, for patients with large perfusion defects. This is based on the premise that poorly perfused lung regions (for example, before the RT treatment of lung, lymphoma or breast cancer) of a heavy smoker patient or a patient with chronic obstructive pulmonary disease will not recover after RT (Theuws et al 1999) .
Several authors suggested incorporating biological information in the evaluation of dose distributions (Niemierko 1997 , Lu et al 1997 . The linear-quadratic-based equivalent uniform dose (EUD) formalism, introduced by Niemierko (1997) for tumours, explicitly allowed for spatial variation of clonogen density. Lu et al (1997) suggested calculating functional normal tissue complication probability (fNTCP) from functional dose volume histogram data. Nonetheless, current clinical treatment planning and evaluation tools still assume homogeneous activity/function status in the tumour/critical structures. For tumours, this assumption is not valid since tumour growth/function is heterogeneous. On the other hand, in most organs, functional status is relatively homogenous, such as the normal liver and normal lung. Such organs are constituted from many relatively identical and homogeneously distributed functional sub-units which are arranged in a parallel architecture (Yorke et al 1993 , Staverv et al 2001 . However, for example, functional heterogeneity within the lung is present in many patients with lung cancer. Furthermore, for many other organs the function is not uniformly distributed. For example, there are dominant and non-dominant portions of the brain, and the left ventricle of the heart is functionally the most important chamber. The biological/physiological outcome of tumour and critical structures (heart, lung, brain etc) irradiation may correlate better with predictions from biological models that incorporate dose-function and dose-volume information, compared to models that incorporate dosevolume information only (Marks et al 1997 , Choi et al 2002 . In this work, a method was developed to incorporate tumour and critical structure heterogeneous activity/functionality in the calculation of the generalized equivalent uniform dose (EUD).
Materials and methods

Functional EUD calculation
The generalized EUD concept proposed by Niemierko (1999) is a phenomenological model based on the power law dependence of the response of a biological system to a stimulus. The EUD can be calculated from the differential dose-volume histogram (DVH) of an anatomical structure as
where N is the number of DVH bins, D i and v i are the dose and volume in the ith bin, a is a tumour or critical structure specific parameter which describes the dose-volume effect and can be obtained from clinical outcome data (Emami et al 1991 , Wu et al 2002 . The generalized EUD can be used to evaluate dose distributions in the tumour and surrounding critical structures. It reports the generalized mean value of the non-uniform dose distribution, which represents the homogenous dose distribution that produces the same local control as that obtained with an inhomogeneous dose distribution for the case of tumours. For the case of critical structures, the generalized EUD reports the homogeneous dose distribution which results in the same probability of complication as that of an inhomogeneous dose distribution. The optimal IMRT plan is the plan that maximizes the EUD in the target and minimizes the EUD in critical structures. The formalism in equation (1) assumes functional uniformity in the response of tumour and critical structures to irradiation. Wu et al (2002) described that for partial organ irradiation the parameter a is related to the parameter n of the Lyman and Wolbarst (1987) partial volume irradiation effect model by a = 1/n. Furthermore, Wu et al (2002) explained that in the context of partial organ irradiation, where a fractional volume of the organ receives a certain dose and the rest of the volume receives no dose. The generalized EUD reduces to the power law model of Lyman and Wolbarst (1987) and to the effective uniform dose formula of Mohan et al (1992) which reports non-uniform dose distribution as an effective uniform dose. Kutcher and Burman (1989) , Kutcher et al (1991) used the power law model to reduce the DVH into an effective volume (V eff ) for the calculation of complication probabilities. The a parameter values in this work were calculated based on the work of Burman et al (1991) using the clinical outcome data of Emami et al (1991) . Specifically, we used the tolerance dose values to the whole organ and partial volumes that would result in a 5% complication probability in 5 years (TD5/5)
Modifying the EUD formalism by replacing volume weighting with function weighting in equation (1), the tumour and critical structures activity/function can be incorporated in the calculation of EUD (FEUD). The FEUD can be calculated from the differential dose-function histogram (DFH) as
where D i and f i are the dose and value of function in the ith bin and N is the number of DFH bins. Unlike the DVH which assumes functional homogeneity, the DFH provides quantitative 3D functional information by incorporating the heterogeneous functionality of tumour or critical structure volumes (Marks et al 1995 (Marks et al , 1999 .
In the DFH calculation and FEUD formalism, the activity/function of tumour/critical structures sub-units was assumed proportional to the number of counts/volume on FDG-PET and SPECT functional images. The assumption was made based on recent papers which have demonstrated that there is strong evidence linking the magnitude of FDG uptake in target to tumour grade (Berlangieri et al 1999 , Albes et al 2002 , Shon et al 2002 , Chin et al 2002 and linking higher uptake to poorer post-therapy response (Kole et al 1999 , Saunders et al 1999 This suggests that the level of FDG-PET activity correlates to tumour aggressiveness and, consequently, the spatial distribution of FDG-PET activity correlates to the spatial distribution of tumour aggressiveness. For SPECT perfusion data, phantom and animal studies (Osborne et al 1982 (Osborne et al , 1985 have shown that SPECT count rates are linearly correlated with blood flow. Moreover, clinical data using SPECT perfusion imaging to predict pulmonary function following surgery suggest that regional function is approximately linearly related to regional perfusion (Kristersson et al 1972 , Wernley et al 1980 , Bria et al 1983 .
The DFHs used in the calculation of FEUD were generated as follows (Marks et al 1999) . First, the PET/SPECT images were registered with the 3D planning CT scan, and hence with the RT dose distribution. The number of PET/SPECT counts at each dose level was calculated to generate PET/SPECT count histograms. As the number of FDG-PET counts is proportional to tumour proliferation and SPECT counts is proportional to the amount of perfusion, and using FDG-PET activity as the measure of tumour aggressiveness/proliferation and perfusion as the measure of function, the PET/SPECT count histograms may be termed dose function histograms (DFH). The FDG-PET/SPECT scans provide quantitative data regarding the relative function/activity of one region compared to other regions and therefore can be summed to calculate DFHs in a manner similar to DVHs.
The optimal plan is the plan that maximizes the FEUD in the target and minimizes the FEUD in each critical structure. The higher target FEUD value implies higher tumour activity is targeted and this may result in improved local control. A lower critical structure FEUD value implies more sparing of functional sub-units, which may result in lower complications.
Treatment planning
To demonstrate the utility of the FEUD formalism, the lung dose distributions of two nonsmall cell lung cancer patients, who received 3D conformal external beam RT treatment at our institution with curative intent, were evaluated. Both patients were treated with 15 MV AP-PA fields to include the gross tumour volume (GTV) and the elective nodal volume followed by off-cord oblique boost to the GTV. The GTV of the first patient (patient-1) was treated to a prescription dose of 62 Gy to the 100% isodose volume, and the GTV of the second patient (patient-2) was treated to a prescription dose of 73.6 Gy to the 93% isodose volume. In both patients, the elective nodal areas were treated to 45 Gy. The treatment plans were generated using the PLUNC (Plan University of North Carolina) treatment planning system. The lungs SPECT scans were registered with the 3D planning CT scans, and consequently the RT dose distribution, using the image registration software of the PLUNC system. The lungs dose distributions were evaluated using the generalized EUD and FEUD models with a lung a value of 0.96.
Furthermore, a non-small cell lung cancer patient, who had previously received 3D external beam RT treatment at our institution, was inversely planned using the optimization algorithm of the PLUNC treatment planning system (Chang et al 2002) . The target (PET-CT-GTV) was defined as the union of the FDG-PET avid regions of the GTV and the CT-outlined GTV, both segmented by the radiation oncologist. A target dose prescription of 76 Gy to the PET-CT-GTV was used. PET and SPECT scans of the patient were registered with the 3D planning CT scan using the PLUNC system. Then, based on the CT, FDG-PET and SPECT treatment planning images of the target and critical structures, two IMRT plans (plan-A and plan-B) were generated using dose-volume objective functions.
The IMRT plan-A and plan-B were generated with the same objective function and using the same dose-volume constraints but with different importance weighting parameters. The IMRT plan-B was generated with the goal of achieving more critical structures sparing and more functional volume target coverage than plan-A. To achieve this goal, higher importance weighting was used for the PET-GTV, lungs and heart dose-volume objective functions. A four coplanar 15 MV field set-up was used for the IMRT plans. The IMRT plans were compared using the generalized EUD and FEUD models. The calculated a values of -10, 0.96 and 3.1 were used for the target, lung and heart, respectively.
For both the 3D and IMRT conformal plans, the dose distributions were calculated using the differential scatter-air ratio algorithm (Sontag and Cunningham 1978) and were corrected for tissue inhomogeneities using the Batho power law model (Batho 1964) .
Results and discussion
Figures 1(a) and (c) show the relative dose distributions on a transverse SPECT image along with the target, lungs and skin contours for patient-1 and patient-2, respectively. Figures 1(b) shows the lungs DVH and DFH with the EUD value of 21.13 Gy and the FEUD value of 10.48 Gy for patient-1. Figure 1(d) shows the DVH and DFH for patient-2 with the EUD value of 11.84 Gy and FEUD value of 20.61 Gy. The dose distributions superimposed on the SPECT image along with the DFH plot for patient-1 show a significant amount of the perfused right lung was spared. Most of the dose delivery was confined to the left non-functional lung where very large SPECT perfusion defects were present next to the CT-defined lung tumour, as shown in figure 1(a) . The lungs FEUD value was lower than the EUD value by a factor of 2. The physiological outcome of the lung irradiation would be better quantified by reporting the DFH and FEUD data which are lower than the DVH and EUD data, indicating more sparing of the functional lung.
On the other hand, the lungs dose distribution and DFH data of patient-2 shown in figures 1(c) and (d) demonstrate that a large functional volume is treated to a significant amount of dose, compared to the DVH. For this patient, the lungs FEUD value was higher than the EUD by a factor of 2. Results suggest that by providing the additional lungs functional data and FEUD value, one may re-plan the patient using other co-planar or noncoplanar beam set-ups to spare more functioning lung regions as much as possible. This may be accomplished by selecting beam directions that traversed low-functioning lung regions and/or less lung volume, versus another that traversed high-functioning lung regions and/or more lung volume. The FEUD and DFH data show that the possibility of radiation-induced damage measured by the reduction in the function of lungs volume in the high dose region is higher, a fact that is not revealed by the DVH and EUD data. figure 2(b) shows that there is an avid area located posteriorly in the right lung. The radiation oncologist and radiologist at our institution diagnosed this area as being atelectatic lung with consripation and inflammation (non-aerated inflamed lung) and therefore was not considered in the 3D treatment of the patient. Figure 3 shows plan-A and plan-B relative isodose distributions on a CT transverse slice. Figure 4 shows the PET-CT-GTV DFH and DVH along with the lungs and heart DFHs. Both IMRT plans show that a relatively homogeneous dose delivery is achieved where the high dose regions are conforming to the target. The dose distributions of the IMRT plans show more critical structure sparing is achieved in plan-B than plan-A at the expense of 'slightly' losing some target volumetric coverage. While the dose distributions in figure 3 and the PET-CT-GTV DVH in figure 4(a) show that IMRT plan-A achieved more target volumetric coverage than plan-B, the PET-CT-GTV DFH in figure 4(b) shows that plan-B was more effective at target activity/function coverage than volumetric coverage. Significantly higher functional volumes of perfused lungs and heart are spared in plan-B than in plan-A, as shown in figures 4(c) and (d). Table 1 lists the EUD and FEUD values for the target and FEUD values for heart and lungs of IMRT plan-A and plan-B. The results in table 1 show that the target volume EUD in plan-B is lower than plan-A by 5%, with a value of 73.31 Gy, which is within 3.5% of the prescription dose. However, the target FEUD in plan-B is lower than in plan-A by only 2.6%, with a value of 75.77 Gy, which is within 0.3% of the prescription dose. The PET-CT-GTV EUD and FEUD values of plan-A are within 1.6% and 2.3% of the prescription dose. The heart and lungs plan-B FEUD values are lower than plan-A by 22% and 18%, respectively. While the EUD values, which assume functional uniformity of the target and critical structures, show that plan-A is marginally better than plan-B for target coverage, the FEUD values of plan-B show adequate target activity/volume coverage with significant critical structure function sparing. For both IMRT plans, beam directions were selected to achieve optimal sparing of the heart and left lung functions. This resulted in FEUD values that are slightly smaller than the EUD values (within 1 Gy) for heart and lungs in both plans. The FEUD model, unlike the TCP and NTCP models, provides a tool for the evaluation of dose distributions which takes into account the non-linearity of tissue dose-function response without attempting to make predictions of absolute outcome. This makes FEUD an attractive method for the evaluation and comparison of dosimetrically guided and biologically guided dose distributions. The FEUD concept can be used for the evaluation of conventional dose distributions and is not limited to 3D conformal and/or IMRT plans. We applied the concept of FEUD to 3D conformal and IMRT plans to stress the importance of using biological metrics for the evaluation of conformal dose distributions. The FEUD concept can also be used to evaluate dose distributions with pre-and post-treatment functional imaging data of the patient. For example, by examining the pre-and post-treatment FEUD values, additional information on tumour shrinkage/reduced activity and radiation-induced damage in normal tissue can be used in the assessment of local control and long-term morbidity at follow-up.
The IMRT treatment plans in this work were steered by dose-volume objective functions and evaluated by FEUD. In a future work, we are planning to perform IMRT planning using objective functions that include functional imaging data information and evaluate the dose distributions using the FEUD model. We will report the results in a future article.
Conclusions
A method to incorporate functional status in the calculation of EUD for radiotherapy dose distributions was developed. The method accounts for the functional heterogeneity of tumour and critical structures volumes by calculating the functional EUD using dose-function histograms. Results from 3D conformal and IMRT plans for lung cancer patients show that incorporating functional imaging data in the calculation of EUD is important in evaluating the biological merit of dosimetrically guided or functional-guided IMRT dose distributions.
